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Abstract
Background: Community pharmacy Common Ailments Services can ease the considerable workload pressures on
primary and secondary care services. However, evidence is needed to determine whether there are benefits of
extending such services beyond their typically limited scope. This study therefore aimed to evaluate a new
community pharmacy model of a service for patients with ear, nose and throat (ENT) and eye conditions who
would otherwise have had to seek primary care appointments or emergency care.
Methods: People with specified ENT or eye conditions registered with General Practitioners in Staffordshire or
Shropshire who presented at participating community pharmacies were offered a consultation with a pharmacist
trained to provide the service. The service included provision of relevant self-care advice and, where clinically
appropriate, supply of non-prescription medicines or specified prescription-only medicines (POMs), including
antibiotics, under Patient Group Directions. Patients received a follow up telephone call from the pharmacist five
days later. Data were collected on the characteristics of patients accessing the service, the proportion of those who
were treated by the pharmacist without subsequently seeing another health professional about the same condition,
and patient reported satisfaction from a questionnaire survey.
Results: A total of 408 patients accessed the service, of whom 61% received a POM, 15% received advice and
medicine supplied under the common ailments service, 9% received advice and purchased a medicine, 10%
received advice only and 5% were referred onwards. Sore throat accounted for 45% of diagnoses where a POM was
supplied, 32% were diagnosed with acute otitis media and 15% were diagnosed with acute bacterial conjunctivitis.
The number of patients successfully followed up was 309 (76%), of whom 264 (85%) had not seen another health
professional for the same symptoms, whilst 45 (15%) had seen another health professional, usually their GP. The
questionnaire was completed by 259 patients (response rate 63%) of whom 96% reported being very satisfied or
satisfied with the service.
Conclusions: The study demonstrates that pharmacists can effectively diagnose and treat these conditions, with a
high degree of patient satisfaction. Wider adoption of such service models could substantially benefit primary care
and emergency care services.
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Background
Common or Minor Ailments Services provided by
community pharmacies offer an alternative location for
patients to receive advice and treatment, rather than
seeking treatment from their GP, out of hours provider
(OOH), walk-in centre or accident and emergency
department (A&E). This is part of an ongoing health
policy move towards upskilling community pharmacists
to provide more clinical services for patients and as a
means of managing the considerable workload pressures
on GPs, A&Es and OOHs [1–5]. In 2016–17 there were
23.4 million attendances at A&E in England, which
compared to attendances in 2015–16 is an increase of
2% and an increase of 22% since 2007–08 [6]. Similarly,
GPs’ overall workload was found to have increased by
16% between 2007 and 2014 [7], whilst a recent Kings’
Fund report found an increase in face-to-face patient
contacts with GP surgeries of 2% and an increase of
24.5% in patient telephone contacts in 2016–17 com-
pared to 2014–15 [8]. Subsequently, the GP Forward
View promoted the provision of evidence-based com-
mon ailments services from community pharmacies [9].
The evidence to date suggests that when common
ailments are managed by community pharmacists most
patients’ symptoms resolve, few patients subsequently
consult another health professional for the same condi-
tion and the cost of the pharmacist consultation is
substantially lower than a consultation with a GP or
attendance at A&E or OOH [10–23]. In a systematic
review of 31 evaluations of minor ailment services, it
was found that rates of symptom resolution ranged from
68 to 94% and reconsultation rates ranged from 2.4 to
23.4% [10]. A study published in 2015 compared the
costs of consultations with community pharmacists with
GP appointments and A&E attendances, and found the
mean cost of community pharmacist consultations to be
£29.30, which was nearly a third of the mean cost of GP
appointments (£82.10) and nearly five times less than
the mean cost of A&E attendances (£147,09) [11]. In a
study that determined costs from where patients said
they would have gone had the common ailment service
not been available, it was estimated that the service
resulted in a substantial reduction in local health care
costs [12].
The range of common ailments eligible for manage-
ment under common ailments services previously
evaluated in the literature varies considerably, but does
not usually include conditions for which antibiotics or
other Prescription Only Medicines (POMs) may be
supplied for, except in a minority of services [22]. These
services only appear to have included infective conjunc-
tivitis and uncomplicated urinary tract infection where
antibiotics could be supplied [22]. The limited formulary
that pharmacists may supply medicines from under
common ailments schemes has been previously reported
to be a barrier to patient care [23], which suggests that
extension of such services to include common condi-
tions requiring supply of antibiotics and other POMs
may be beneficial.
However, an evaluation of an extended common
ailments service that includes conditions requiring
antibiotics or other POMs does not appear to have
previously been reported in the literature and so we
report an evaluation of such an extended service for
common ear, nose and throat (ENT) conditions and
bacterial conjunctivitis. The evaluation aimed to assess
the outcomes of the extended service in terms of patient
reported satisfaction, patient uptake characteristics and
the proportion of patients accessing the service who
could be treated by the pharmacist without them subse-
quently seeing another health professional about the
same condition.
Methods
Description of the service initiative intervention
The Pharmacy First Extended Care Service for ENT &
Eye conditions aimed to provide eligible patients
registered with a GP practice contracted to NHS
England, Staffordshire and Shropshire Area (NHSE S&S)
with access to medication via community pharmacies for
the treatment of specified ENT conditions and for acute
bacterial conjunctivitis not suitable for treatment under
the Pharmacy First Common Ailments Service (PFCAS).
The specific ENT conditions included were acute otitis
externa, acute otitis media, acute bacterial sinusitis,
chronic sinusitis, seasonal allergic rhinitis, and sore
throat. These ENT conditions were chosen on the basis
of being among the most common category of pre-
senting conditions to the local A&E departments and
the specific conditions being commonly occurring
within the category. Acute bacterial conjunctivitis was
included because analysis of PFCAS data indicated
that it was a common reason for GP referral by
community pharmacists.
Consenting patients had a consultation with a pharma-
cist where their symptoms and their medical and
medication history were assessed (with reference to their
Summary Care Record wherever possible). The pharma-
cist examined the patient, assessed their treatment needs
and determined whether they met specific inclusion
criteria to be managed under the extended care service.
For patients who were included, pharmacists gave
self-care advice (including what to do if their symptoms
did not resolve or their condition worsened) and, where
clinically appropriate, supplied non-prescription medi-
cines either purchased by the patient or through the
PFCAS. Where antibiotic treatment or other POMs ap-
peared to be necessary the pharmacist supplied these
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under Patient Group Directions (PGDs) specific to each
condition and the GP practice was informed. The
antibiotic that could be supplied was specified in each
PGD (with an alternative in case of allergy or other
contraindication) at a fixed dose, frequency and duration
of treatment. Antibiotic choices in PGDs complied with
local antibiotic formularies to take account of local
antibiotic resistance patterns. The service also allowed
deferring antibiotic treatment, which meant that if the
patient returned after waiting a pre-defined number of
days, the antibiotic could be supplied without repeating
the consultation.
As part of accessing the service, all patients agreed to
be contacted by the pharmacist approximately 5 days
after their consultation for a short telephone interview
to follow up on how successful the treatment had been
and whether they had since seen another health profes-
sional for the same condition.
The service started in late November 2017 and was
provided through ten community pharmacies contracted
to NHSE S&S that had signed the Service Level Agree-
ment (SLA). These pharmacies were selected for the
service on the basis of having responded to a call for
expressions of interest and meeting pre-defined criteria.
These included that the pharmacies had to have an
accredited consultation area approved for delivery of
advanced services (i.e. clearly signed as a private consult-
ation area, where the patient and pharmacist can sit
down together and talk at normal speaking volume with-
out being overheard by staff or customers) and that two
pharmacists from each pharmacy had completed be-
spoke, online and face-to-face training on diagnosis and
management of the ENT and eye conditions. The
training was developed and delivered by a team that in-
cluded two GP trainers in examination skills and
pharmacist facilitators. This included training pharma-
cists on recognising ‘red flag’ signs and symptoms poten-
tially indicative of a more serious condition, diagnosis in
vulnerable groups and how to use diagnostic equipment
(otoscope, torch and digital ear thermometer). Partici-
pating pharmacies were supplied with the additional
equipment necessary (e.g. an otoscope) and were able to
provide the service to a limited number of patients each,
based on the funding secured. The service was funded
by the North West Midlands Urgent and Emergency
Care Network, which included the training and supply
of additional equipment, and project managed by Local
Pharmaceutical Committees (LPCs). Additional top-up
funding was awarded to the project by NHSE S&S Local
Professional Network for pharmacy.
Data collection and analysis
The evaluation used two methods of data collection:
PharmOutcomes to record service access data and a
questionnaire survey as a means of collecting patient
satisfaction data. PharmOutcomes was used as a means
of collecting data about patient uptake and outcomes of
the service because it is already used by community
pharmacies in the study location to record and be remu-
nerated for delivery of commissioned services. Recording
modules can be written for this web-based system to
match service specifications and PGDs, resources and
links can be embedded into the system to allow the
pharmacy team easy access to local documents and any
relevant national guidance. Recording service delivery
data on the system allows local and national level
analysis on the effectiveness of commissioned services.
All personally identifiable information was removed
from the data downloaded from PharmOutcomes for the
evaluation, but patient age, gender, ethnicity and the first
part of their postcode were included. Anonymous
patient satisfaction data were collected using a question-
naire because community pharmacy customers tend to
be familiar with the format as it is commonly used by
pharmacies and GP surgeries for gaining patient
feedback. As a service evaluation, ethical approval was
not required.
Questions were set up in PharmOutcomes for pharma-
cists to answer as consultations progressed to guide the
consultation and ensure that standardised information
was recorded. These questions were mapped to the SLA
and PGDs. This included the outcome of pharmacists’
consultations with patients in terms of supply of
non-prescription medicine (either purchased or supplied
under the PFCAS), as well as the diagnosis made and
the numbers of those who were supplied with a POM,
not supplied with any treatment or were referred.
For the follow up telephone interviews, pharmacists
attempted to contact all patients who had received the
extended care service to determine whether they had
subsequently seen another health professional about the
same condition within 5 days of seeing the pharmacist
and, if so, which professional they had seen. This data
was recorded in PharmOutcomes. Where patients had
seen another health professional they were asked why
and a free text response was recorded in PharmOut-
comes. This data was thematically categorised and
frequency counted.
Patients who received the extended care service were
also given a pack containing an invitation letter, a patient
satisfaction questionnaire and a pre-paid envelope. They
were invited to complete the questionnaire anonymously
and post it back to the pharmacy, or anonymously
complete an online version. The questions were de-
signed as fixed response rather than free text and were
developed from standard questions used in numerous
other evaluations according to the aims of the evaluation
of the extended care service. These included whether
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patients would use the service again, or recommend the
service to others, reasons for using the service, and how
they found out about the service, as well as asking them
to rate their satisfaction with the service they had
received on a 5 point Likert scale.
Data recorded in PharmOutcomes were downloaded
into a Microsoft Excel spreadsheet and anonymised
before being sent to a researcher (SW) who was inde-
pendent of the service delivery and administration.
Questionnaire data was manually inputted into Excel.




A total of 408 patients accessed the service, of whom
247 (60.5%) were women and 161 (39.5%) were men.
Patients accessed the extended care service between late
November 2017 and 6th March 2018, at which point the
total allocated number of patients had been reached.
The majority of patients (323, 79.2%) selected White
British as their ethnicity, with other White ethnic origins
selected by 11 (2.7%) of respondents and 18 (4.4%)
respondents selecting Black, Asian or Minority Ethnic
groups. A total of 53 (13%) selected the ‘prefer not to
say’ option about ethnicity.
Table 1 shows the outcomes of consultations recorded
in PharmOutcomes. The data indicates that for over 60%
of patients this resulted in supply of a POM, whilst the
remaining third of patients were managed with
non-prescription medicines (also known as over the
counter (OTC) medicines) and / or self-care advice, and
only a small minority were referred for medical atten-
tion. The diagnoses made for those patients who were
supplied with a POM are shown in Table 2, of which
sore throat and acute otitis media were the most
common. Table 3 shows the numbers and percentages of
patients supplied with POMs for each indication and the
numbers and percentages of deferred antibiotics.
Of the total of 408 patients who accessed the extended
care service, 309 (76%) were successfully contacted by
telephone approximately 5 days after their initial consult-
ation. Of these, 264 (85%) reported that they had not
seen another health professional. The other 45 (15%)
patients reported that they had seen another health
professional, which in the majority of cases (78%) had
been a GP, but 11% reported having returned to the
pharmacy and a small minority had seen a practice nurse
(2%) or attended an OOH (2%). None of the patients
had gone to A&E. The reasons reported by patients for
this are shown in Table 4.
Patient questionnaire data
Questionnaire responses were received from 259
patients, which represents a response rate of 63%. There
were nearly three times the number of female respon-
dents (185, 73%) compared to males (65, 27%) and the
mean age for women and men was 32 and 39 respect-
ively. The age range for females was 0–77 and for 4–80
for males, indicating that parents or guardians com-
pleted the questionnaire on behalf of younger patients.
Age or gender data were not recorded for 9 patients.
The vast majority of patients reported being very
satisfied or satisfied with the service, with only 3 (1%)
patients reporting being unsatisfied. The question was
not answered by 7 patients.
In addition, 97% of respondents agreed that commu-
nity pharmacies are appropriate places to provide the
extended care service, 98% of respondents reported that
they would use the service again and 99% of respondents
reported that they would recommend the service to
others. The reasons for using the service that were
selected by respondents is shown in Table 5, of which
not needing an appointment to access the service was
the most frequently chosen.
In terms of how respondents had found out that the
extended care service was being provided, 61% of
respondents reported finding out from their GP surgery,
29% from a community pharmacy providing the service
and 7% from word of mouth.
Discussion
Key findings from this study include that the majority of
eligible patients’ ENT or eye conditions could be treated
by the pharmacist without them subsequently seeking
care from their GP, or an OOH or A&E for the same
Table 1 Patient outcomes from pharmacist consultations
Outcomes No. (%)
POM supplied 249 (61)
Advice + OTC medicine supplied via PFCAS 60 (15)
Advice only (no medicines supplied) 41 (10)
Advice + OTC medicine purchased 38 (9)
Onward referral 20 (5)
Total 408 (100)
Table 2 Indications for POMs supplied
Outcomes No. (%)
Sore throat 112 (45)
Acute otitis media 79 (32)
Acute bacterial conjunctivitis 36 (15)
Acute bacterial sinusitis 16 (6)
Acute otitis externa with suspected secondary infection 3 (1)
Chronic sinusitis 3 (1)
Total 249 (100)
Hall et al. BMC Health Services Research          (2019) 19:285 Page 4 of 8
condition and that patient-reported satisfaction with this
extended common ailments service was extremely high.
Nearly half of all patients who accessed the service
presented with sore throat and approximately a third
had acute otitis media. Over 60% of patients seen were
supplied with an antibiotic or other POM. The small
proportion (15%) of patients who reported seeing
another health professional for the same condition after
the consultation with the pharmacist usually saw their
GP and if not because they had been referred to the GP
by the pharmacist, then they most likely did so because
their symptoms had not resolved, despite an initial
course of antibiotics.
The high degree of patient satisfaction was evident in
their overall satisfaction rating, but also in the very high
proportion who indicated that they would use the
service again and recommend it to friends and family.
Being able to access the service without an appointment
seemed to be a key factor for using it, but being aware
that the service was available was also important and
previous studies have shown low awareness among the
general public about the availability of consultation-
based services from community pharmacies [24]. The
high proportion of patients (61%) who reported finding
out about the service from their GP surgery suggests
that surgeries were actively signposting patients to the
service and that this may have been a major reason for
its success.
This study adds to what is already known about
community pharmacists being able to effectively
Table 3 The number of patients supplied with POMs for each indication and the percentage of deferred antibiotics
Indication for POM supply POM supplied No. & % patients treated for
that condition
Acute bacterial conjunctivitis Chloramphenicol eye drops 0.5% 29 (80%)
Chloramphenicol eye drops 0.5% (deferred) 1 (3%)
Fusidic acid eye drops 1% 6 (17%)
Fusidic acid eye drops 1% (deferred) 0
Acute otitis externa with suspected secondary infection Clioquinol and flumetasone ear drops 3 (100%)
Acute otitis media Amoxicillin 66 (84%)
Amoxicillin (deferred) 9 (11%)
Clarithromycin 4 (5%)
Clarithromycin (deferred) 0




Chronic sinusitis and seasonal affective rhinitis Beclometasone nasal spray 50mcg 3 (100%)
Sore throat Phenoxymethylpenicillin 93 (83%)
Phenoxymethylpenicillin (deferred) 5 (4%)
Clarithromycin 14 (13%)
Clarithromycin (deferred) 0
Table 4 Reasons reported by patients for reconsultations
Reconsultation type Reason No.
For GP appointments Symptoms did not resolve 11






Developed more serious illness 4
Wanted second opinion 2
Needed sick note 1
For practice nurse appointment Consulted for additional matter 1
For returning to the pharmacy Symptoms did not resolve 3
For going to an out-of-hours
service
Adverse reaction to antibiotic 1
Total (reason unknown for 7 patients) 38
Table 5 Reasons selected by patients for using the extended
care service
Reasons No.
No need for an appointment 207
Did not have to wait for GP appointment 169
Close to home 150
Convenient opening times 134
Convenient location (near work / shops) 77
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undertake patient consultations and reduce workload
pressures on GPs and A&Es. Previous studies of
common ailments services have shown that despite
variation in service quality [25], community pharma-
cists can effectively treat eligible conditions, with low
reconsultation rates [10–12, 26] and high patient
acceptability [27–29].
The Pharmacy First Extended Care Service for ENT
and Eye conditions included infective or chronic condi-
tions that have not been included in previous types of
common ailment service. Exceptions to this have in-
cluded bacterial conjunctivitis treated with chloram-
phenicol eye drops which has been included in a
minority of services [22], and a feasibility study of com-
munity pharmacy screening and treating streptococcal
sore throat with antibiotics has also been reported [26].
This significantly adds to the range of conditions that
can be diagnosed and treated in community pharmacies.
Previous studies have shown that common ailments
services cost less than GP appointments or A&E atten-
dances [10–12, 16, 18]. It was beyond the scope of this
study to undertake a full economic evaluation of the
Pharmacy First Extended Care Service for ENT and Eye
conditions, but the service did appear to reduce GP and
A&E workload, and so savings were likely to have been
made as the majority of patients would otherwise have
had to see a GP or attend an OOH or A&E for antibiotic
treatment.
The key strength of this study is that it reports on a
substantially extended model of a common ailments
service, which requires pharmacists to have advanced
clinical examination skills, using diagnostic equipment
such as otoscopes. This is an important step in the
further development in the management of common
ailments in community pharmacy, especially as the con-
ditions covered in the service were broadly included in a
list of ailments appropriate for management in commu-
nity pharmacy recently developed using consensus
methodology, which supports the rationale for their
inclusion [30]. Developments of this nature are all the
more important as many areas in England have now
decommissioned their traditional common ailments ser-
vices following publication of recent guidance from NHS
England on OTC products that should not be routinely
prescribed in primary care [31]. This guidance includes
products used for minor ailments and applies to patients
who are exempt from paying prescription charges who
may no longer be able to be supplied with these
products under common ailments services unless their
minor ailment meets specific criteria.
A weakness of the study is that the majority of patients
who accessed the service reported themselves to be
White British and so it is not known whether similar
results would be found in a more diverse patient
population. Other limiting factors include that the
pharmacists had to express interest in order to partici-
pate and so may have been more motivated to provide
the service than may be found if the service were more
widely rolled out. The service requires appropriately
trained pharmacists and participating pharmacies to
have appropriate facilities, including appropriate diag-
nostic equipment, which has a cost implication for wider
roll out. Successful implementation also requires pa-
tients to be aware that the service is available, but the
findings of this study suggest that this can be effectively
done by GP surgeries actively signposting patients to it.
However, whilst the data presented here suggest bene-
fit for patients, as well as workload pressure reduction
for GPs, evaluating the full benefit for patients and the
health economy of any wider uptake of the service
would require an appropriately designed clinical trial,
with economic evaluation. A feasibility study would
likely be needed first to refine the conditions to include
in the service and identify viable primary and secondary
outcomes to determine the effectiveness of the service.
The economic evaluation should include clinical and
humanistic outcomes in addition to economic outcomes
[32]. Qualitative exploration of community pharmacists’
and GPs’ perspectives on the quality of the service
provided might also yield useful insights.
Conclusions
The study demonstrates that pharmacists can effectively
treat these specific ENT and eye conditions, with a high
degree of patient satisfaction and a low proportion of
patients subsequently seeing another health professional
for the same condition. This extends what is already
known about community pharmacists being able to
effectively undertake patient consultations and reduce
workload pressures on GPs and A&Es. Wider uptake of
this service model would be expected to be beneficial for
patients and the health economy, but this would need to
be confirmed by an appropriately designed clinical trial
with economic evaluation. This may represent a natural
evolution for community pharmacy common ailment
schemes and further integrate pharmacy into multidis-
ciplinary primary healthcare provision.
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